The Australia CBD products market size reached USD 0.22 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 0.50 Billion by 2033, exhibiting a growth rate (CAGR) of 9.61% during 2025-2033. The rising demand for CBD products in Australia is driven by increasing interest in alternative medicine, greater product innovation, and a wider variety of offerings, as users seek natural remedies for physical and mental health concerns, favoring personalized, high-quality solutions for wellness.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 0.22 Billion |
Market Forecast in 2033 | USD 0.50 Billion |
Market Growth Rate 2025-2033 | 9.61% |
Enhanced Product Innovation and Variety
The growing innovation in CBD products with businesses providing a more varied selection of offerings is positively influencing the market in Australia. From oils and tinctures to edibles, topicals, and skincare products, the range of CBD choices is increasing to meet a wider array of user preferences and requirements. This advancement is seen not only in the variety of products offered but also in the strength, purity, and bioavailability of CBD, providing more efficient options for individuals. As user preferences move towards tailored products to tackle particular health issues, companies are persistently enhancing formulations and launching novel uses for CBD. A definitive illustration of this trend is the introduction of Tilray Medical’s EU-GMP accredited Redecan cannabis offerings in Australia in 2024. This encompassed premium cannabis products like Redecan PC THC28 Purple Churro and Redecan SA THC28 Space Age Cake, broadening the selection of high-quality, certified CBD items accessible to users in Australia. Tilray Medical is enhancing the expanding range of CBD products and driving market innovation by providing an assorted assortment of high-quality, regulated items. This constant evolution ensures that the Australian CBD market remains dynamic and responsive to individual needs, attracting a wider user base and driving market growth as more people seek tailored solutions for their health and wellness.
Rising Popularity of Alternative Medicine
As traditional medicine faces increasing skepticism, many people are turning to alternative and complementary therapies, which is driving the demand for CBD products. A noticeable shift toward natural remedies is emerging, with more people preferring herbal treatments and plant-based solutions for managing both physical and mental health concerns. Individuals are becoming more educated about the potential benefits of CBD, especially in treating conditions, such as anxiety, insomnia, and chronic pain. This growing awareness is fostering a more open-minded approach, where individuals are willing to explore non-pharmaceutical options. A prime example of this shift is the launch of Charlotte's Web CBD formulation in Australia in 2024. Initially created by the Stanley Brothers to treat Charlotte Figi’s Dravet syndrome, this product garnered widespread media attention due to its success in managing Figi’s epilepsy. The product was locally manufactured and distributed with FoliuMed, marking a significant step in the acceptance of CBD as a legitimate, effective alternative treatment. This kind of high-profile success is contributing to the growing popularity of CBD as an alternative medicine, encouraging more people to seek out these natural solutions for their health needs. As the trend continues, CBD products are being incorporated into everyday wellness routines, supporting the market growth and cementing CBD’s place in the broader movement of natural and holistic health practices.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on source, distribution channel, and application.
Source Insights:
A detailed breakup and analysis of the market based on the source have also been provided in the report. This includes hemp and marijuana.
Distribution Channel Insights:
The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes B2B and B2C.
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes pharmaceutical and wellness.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Sources Covered | Hemp, Marijuana |
Distribution Channels Covered | B2B, B2C |
Applications Covered | Pharmaceutical, Wellness |
Regions Covered | Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, Western Australia |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: